California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on June 2, 2026

Jun. 2, 2026

Board-Certified Podiatrist Issues Consumer Guide to Understanding Custom Orthotics and Cost

Indeterminate EIN Presswire

Jun. 2, 2026

HŪMNZ Launches in Southern California to Help Mid-Market Companies Stabilize, Scale, Capitalize, and Transition

Indeterminate EIN Presswire

Jun. 2, 2026

Coastal Kids Home Care Celebrates Expansion of Rodgers Center for Children's health

Indeterminate EIN Presswire

Jun. 2, 2026

Best Holistic Life Unveils Sam & Shayna Tejada: June 2026 Cover Story

Indeterminate EIN Presswire

Jun. 2, 2026

Gonzales Challenges CA-47 Opponents on Rising Costs, Failing Affordability, and California’s Middle-Class Exodus

Indeterminate EIN Presswire

Jun. 2, 2026

OutCare Health Acquires inclusive+ to Accelerate Access to LGBTQ+ Affirming Care Nationwide

Indeterminate EIN Presswire

Jun. 2, 2026

D&Y Integrated Psychiatry Launches New Website to Expand Access to Telehealth Psychiatry Across California

Indeterminate EIN Presswire

Jun. 2, 2026

Global MR Community Convened in Cape Town for 2026 Annual Meeting as ISMRM & ISMRT Passed the Gavel to New Presidents

Indeterminate EIN Presswire

Jun. 2, 2026

Rula Health Appoints Frank A. Calderoni to its Board of Directors

Indeterminate EIN Presswire

Jun. 2, 2026

DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy

Indeterminate GlobeNewswire

Jun. 2, 2026

DBV Technologies annonce le screening du premier participant de l’étude clinique de phase 2 THRIVE pour le patch VIASKIN® Peanut chez les nourrissons âgés de 6 à 12 mois allergiques à l’arachide

Indeterminate GlobeNewswire

Jun. 2, 2026

Zenas BioPharma Announces Data from the Registrational Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD), Simultaneously Presented at the EULAR 2026 Congress and Published in the New England Journal of Medicine

Indeterminate GlobeNewswire

Jun. 2, 2026

Fortrea to Attend Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 2, 2026

Sayvant Launches Autonomous Patient Chart Analysis for Emergency and Hospital Medicine

Indeterminate EIN Presswire

Jun. 2, 2026

Intermountain Health Research Study Finds AI Technology is a ‘Game Changer’ for the Treatment of Two of the Most Common Chronic Pulmonary Conditions in the World

Indeterminate GlobeNewswire

Jun. 2, 2026

CAHI Honours The Honourable Don Boudria for Leadership in Animal Health

Indeterminate GlobeNewswire

Jun. 2, 2026

L’ICSA rend hommage à l’honorable Don Boudria pour son engagement envers la santé animale

Indeterminate GlobeNewswire

Jun. 2, 2026

Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026

Indeterminate GlobeNewswire

Jun. 2, 2026

Shopify Announces $3 Billion Increase to Share Repurchase Program

Indeterminate GlobeNewswire

Jun. 2, 2026

JASI Skin + Wellness Med Spa in Torrance Champions Full-Face Harmonization Approach as Filler Reversal Trend Grows

Indeterminate EIN Presswire